PTP Accounts Production v24.3.2.46 07112786 director 1.4.23 31.3.24 31.3.24 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071127862023-03-31071127862024-03-31071127862023-04-012024-03-31071127862022-03-31071127862022-04-012023-03-31071127862023-03-3107112786ns15:EnglandWales2023-04-012024-03-3107112786ns14:PoundSterling2023-04-012024-03-3107112786ns10:Director12023-04-012024-03-3107112786ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107112786ns10:SmallEntities2023-04-012024-03-3107112786ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107112786ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107112786ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107112786ns10:AbridgedAccounts2023-04-012024-03-3107112786ns10:RegisteredOffice2023-04-012024-03-3107112786ns5:CurrentFinancialInstruments2024-03-3107112786ns5:CurrentFinancialInstruments2023-03-3107112786ns5:Non-currentFinancialInstruments2024-03-3107112786ns5:Non-currentFinancialInstruments2023-03-3107112786ns5:ShareCapital2024-03-3107112786ns5:ShareCapital2023-03-3107112786ns5:RetainedEarningsAccumulatedLosses2024-03-3107112786ns5:RetainedEarningsAccumulatedLosses2023-03-3107112786ns5:FurnitureFittings2023-04-012024-03-3107112786ns5:MotorVehicles2023-04-012024-03-3107112786ns5:ComputerEquipment2023-04-012024-03-31
REGISTERED NUMBER: 07112786 (England and Wales)















Abridged Unaudited Financial Statements for the Year Ended 31 March 2024

for

N & T MEDICAL LIMITED

N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


N & T MEDICAL LIMITED

Company Information
for the Year Ended 31 March 2024







DIRECTOR: Dr N Melikian





REGISTERED OFFICE: 27 Daventry Street
London
NW1 6TD





REGISTERED NUMBER: 07112786 (England and Wales)





ACCOUNTANTS: Garo & Co UK LLP
Chartered Certified Accountants
27 Daventry Street
London
NW1 6TD

N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)

Abridged Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 26,271 32,687
Investment property 5 528,826 528,826
555,097 561,513

CURRENT ASSETS
Debtors 18,989 25,514
Cash at bank 444,985 396,303
463,974 421,817
CREDITORS
Amounts falling due within one year 41,346 31,908
NET CURRENT ASSETS 422,628 389,909
TOTAL ASSETS LESS CURRENT
LIABILITIES

977,725

951,422

CREDITORS
Amounts falling due after more than one
year

6

(330,626

)

(349,855

)

PROVISIONS FOR LIABILITIES (5,600 ) (6,500 )
NET ASSETS 641,499 595,067

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 641,498 595,066
SHAREHOLDERS' FUNDS 641,499 595,067

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)

Abridged Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 December 2024 and were signed by:





Dr N Melikian - Director


N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

N & T Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Motor vehicles - 15% on cost
Computer equipment - 25% on cost

Investment property
Investment properties are properties held to earn rentals and/or for capital appreciation. Investment properties are initially measured at cost, including transaction costs. Subsequently investment properties whose fair value can be measured reliably without undue cost or effort on an on-going basis are measured at fair value. Gains and losses arising from changes in the fair value of investment properties are included in profit or loss in the period in which they arise.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Fixed asset investments
Fixed asset investments in Limited Liability Partnerships are measured at cost less permanent impairment.

Permanent impairments are taken to the Company's profit and loss account.

N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

2. ACCOUNTING POLICIES - continued

Going concern
The director has continued to assess the Company's trading results at the time of signing the financial statements and confirms that it has adequate resources available to meet its liabilities as they fall due, allowing the Company to continue in operational existence for a period of twelve months from the date of signing these financial statements.

The director therefore believes that it is appropriate for the financial statements to be prepared on the going concern basis..

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2023
and 31 March 2024 40,945
DEPRECIATION
At 1 April 2023 8,258
Charge for year 6,416
At 31 March 2024 14,674
NET BOOK VALUE
At 31 March 2024 26,271
At 31 March 2023 32,687

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 April 2023
and 31 March 2024 528,826
NET BOOK VALUE
At 31 March 2024 528,826
At 31 March 2023 528,826

The fair value of this property at 31 March 2024 has been arrived at on the basis of a valuation carried out at that date by Dr Narbeh Melikian, the director of the company who is not a professionally qualified valuer. The valuation, which does not differ from the cost at the date of acquisition and the property improvement costs, was arrived at by reference to market evidence of transaction prices for similar properties in its location and takes into account the economic forces of the rental market in the area where the property is situated.

N & T MEDICAL LIMITED (REGISTERED NUMBER: 07112786)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
31.3.24 31.3.23
£    £   
Repayable by instalments
Mortgage 309,793 319,855

7. SECURED DEBTS

The bank loan included under creditors is supported by a guarantee from the UK Government to the bank under the Bounce Back Loan Scheme (BBLS).

The bank loan bears interest of 2.5% per annum.

The mortgage is secured by a fixed charge over the investment property held by the company.